Objective: The Oslo Diet and Antismoking study was a 5-year randomised trial initiated in [1972][1973], which studied the effect of dietary change and smoking cessation for the prevention of coronary heart disease among high-risk middle-aged men. To test the long-term maintenance of lifestyle change, we examined diet and cardiovascular risk factors in subjects initially randomised to the control and intervention groups 20 years after cessation of the intervention. Subjects and design: Of the original cohort that included 1232 participants, 910 survivors were identified in 1997 and cardiovascular risk factors were measured in 563 (62%) in 1997-1999. Of these, 558 (99%) also completed questionnaires about their food intake and attitudes to health and diet. Results: Cigarette smoking was nearly halved between baseline and 20-year follow-up in each of the intervention and control groups (Po0.001 within groups), but did not differ between the intervention group (39%) versus the control group (34%); P ¼ 0.07. Body mass index increased by 1.472.6 and 1.672.6 kg/m 2 between baseline and 20-year follow-up in the intervention and control groups, respectively (Po0.001 within groups; NS between groups). Serum total cholesterol and triglyceride concentrations decreased substantially in subjects treated or untreated with statins (Po0.001 within the intervention and control groups) but did not differ between the groups (total cholesterol change of À1.471.3 and À1.371.2 mmol/l, respectively, and triglyceride change of À0.571.0 mmol/l in both groups). Men in the intervention group reported a less atherogenic fat quality score and lower intakes of fat, saturated fat and cholesterol, higher intakes of long chain polyunsaturated fatty acids, protein and beta-carotene and greater attention to lifestyle and change of diet than the control group (all Po0.05). The fatty acid concentrations did not differ, however, between the intervention and control groups (P40.05). Conclusions: No long-term differences in smoking rates or lipid concentrations between the intervention and control groups were observed in the surviving attendees two decades after the end of the trial. Lifestyle intervention still influenced the dietary intake, though modestly.
Introduction
Serum cholesterol is one of the most important modifiable risk factors for coronary heart disease (CHD). Despite the effectiveness of statins in reducing serum low-density lipoprotein (LDL) cholesterol concentrations, diet remains the cornerstone of treatment for hyperlipidaemia (National Cholesterol Education Program, 2001 ; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice, 2003) . The primary dietary changes that decrease cholesterol concentrations are the substitution of nonhydrogenated unsaturated fat for saturated and trans-fats and the reduction of dietary cholesterol (National Cholesterol Education Program, 2001; Connor and Connor, 2002 ; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice, 2003) . In population trials, dietary modification leads to about a 5% reduction in serum total cholesterol concentrations after 12 months (Tang et al., 1998) though not a statistically significant reduced risk of cardiovascular events (Hooper et al., 2001) . A diet involving a more Mediterranean food pattern reduced CHD, even though serum LDL cholesterol concentrations were not lowered (de Lorgeril et al., 1994) . In addition to this trial, other data buttresses the notion that increased consumption of omega-3 fatty acids, fruits, vegetables, nuts and whole grains protects against CHD (Hu and Willett, 2002) . Serum cholesterol concentrations are reduced by weight loss (Dattilo and Kris-Etherton, 1992) . However, no randomised, controlled clinical trial has to date established that weight loss reduces the incidence of CHD.
Even though dietary change has an established record in preventing CHD, the long-term feasibility and effectiveness of lipid lowering diets in free-living populations is controversial (Tang et al., 1998) . A small number of studies have addressed the long-term maintenance of protective dietary practises following dietary counselling; however, these studies have only followed their subjects for 1 to 3.5 years after the cessation of intervention (Cutler et al., 1991; Kristal et al., 1992) . Data regarding the sustainability of dietary advice among free-living individuals for decades have not been shown.
The Oslo Diet and Antismoking Study was a 5-year primary prevention trial that demonstrated the protective effect of dietary and antismoking advice on CHD among high risk, middle-aged men. The intervention reduced the incidence of CHD as previously described in an initial publication and in further analyses Hjermann et al., 1986; Ellingsen et al., 2003) . In this report, we examined the long-term maintenance of dietary advice among study survivors 20-21 years after the trial was ended and studied the impact of randomisation to the intervention or control groups on body weight, body mass index (BMI) and serum lipid and fatty acid concentrations.
Subjects
The Oslo Diet and Antismoking Trial was initiated in 1972 as a primary prevention study that sought to establish whether lowering of serum cholesterol and cessation of smoking reduced the incidence of CHD. The study and its outcome have been extensively described in previous publications (Hjermann et al., , 1986 Ellingsen et al., 2003; Holme et al) . Briefly, 1232 healthy men aged 40-49 years with elevated serum total cholesterol or a high coronary risk score, invited from a pool of 16 202 screened men (65% of all men aged 40-49 years in Oslo), were included in 1972-1973. All subjects had a normal electrocardiogram at rest, were free of chest pain at exercise testing, and were free of diseases in the cardiovascular system, hypertension, diabetes mellitus, cancer, disabling or psychopathological conditions and alcoholism. Men on lipid-lowering diets were excluded. Subjects in the intervention group (n ¼ 604) were counselled by the physician and dietitian at visits every 6 months during 5 years, while controls (n ¼ 628) were seen at 12-month intervals and were not given dietary or antismoking advice (Hjermann et al., , 1986 Hjermann, 1981; Ellingsen et al., 2003) .
In 1997-1999, the survivors (n ¼ 910) were invited to a reexamination and to participate in the Diet and Omega-3 fatty acid Intervention Trial on atherosclerosis (DOIT) (Hjerkinn et al., 2000) . In order to contact all survivors, the 11-digit personal number of each subject was linked to vital status in Statistics Norway. Between 1972 and 1996 there were 322 deaths, of which 153 were in the intervention group and 169 in the control group. Of survivors, 255 men did not respond to the re-examination invitation, 92 responders were excluded because of unwillingness to participate, serious illness or difficulties with transportation, thus 563 were left for inclusion in the re-examination. Of these, 558 supplied dietary information. Data on medical history including the presence of diabetes or cardiovascular disease, use of cholesterol-lowering drugs and on other lifestyle factors was obtained by questionnaire. In regard to cigarette smoking, subjects were asked whether they smoked daily at present (yes or no) and the response was compared with the response to the same question at baseline. Body weight and height were measured with the subject barefoot and wearing light clothing. BMI was calculated as kg/m 2 . The regional Ethics Committee approved the study, and all subjects gave their informed written consent to participate.
Methods

Dietary intervention in the trial
A trained dietitian and the lead investigator (IH) gave dietary advice individually and during group sessions conducted between 1972/1973 and 1977/1978 . All subjects were advised to reduce dietary saturated fat and cholesterol and to slightly increase polyunsaturated fat intakes. Subjects with elevated triglyceride concentrations were asked to reduce total energy intake (mainly by reducing sugar, sweet drinks, chocolate, alcohol and fat intake). All subjects were asked to consume fibre-rich bread with no or only a thin layer of highly polyunsaturated low fat margarine. Preferred spreads included fish, vegetables, fruit, low sugar jam, and low-fat meats and cheeses. Skimmed milk and no more than 1 egg/ week were recommended. For main meals, use of lean meat, fish and low-fat fish products together with potatoes and vegetables was advised. Cigarette smokers were urged to stop smoking.
Fat quality score A short diet history of eight food items was recorded at the initial screening in 1972-1973 and calculated again in 1997-1999 based on the data obtained from the food frequency Effect of diet and smoking on CHD I Ellingsen et al questionnaire. Subjects were asked to quantify their consumption of hard margarine or butter, cooking oil, whole milk, cream, cheese, eggs, cakes and pastries and lean or fatty meats. Scores for each dietary item were summarised into a fat quality score (Leren, 1966) , with low scores indicating a high-coronary risk diet. The maximum possible score was 50 points. Thus, consumption of 4250 g/week of margarine or butter, 41 l/week of whole milk, daily cream or cakes/pastry, 460 g/day of cheese, 43 eggs/week, 0-50 g/week of soybean oil or avoidance of lean meat gave a score of 0 points each for each item, while consumption of 0-50 g/week of margarine or butter, 0-0.25 l/week of whole milk, or 4250 g/week of soybean oil gave a score of 8 points for each item.
Dietary data at follow-up in 1997-1999 Participants completed an optically read quantitative food frequency questionnaire (FFQ) designed to cover the whole diet. The FFQ was developed and evaluated at the section for Dietary Research, Institute for Nutrition Research, University of Oslo Norway (Andersen et al., 1996 (Andersen et al., , 1999 Solvoll 2000) . The FFQ include 190 food items, which were selected on the basis of Norwegian dietary patterns obtained in previous dietary surveys. The food items represented in the FFQ followed a traditional meal pattern consisting of bread-based meals and a main meal (dinner). The food items were grouped into 14 sections based on these food items and meal type. There were additional sections for dietary supplements and regarding attitudes towards diet and health.
The FFQ and a written instruction formula were handed out to participants to complete at home and return at the following visit. Participants were asked to fill in the food items as number of portions and frequency of consumption. To avoid inaccuracy, a trained nurse or nutritionist (IE) checked and corrected forgotten and missing information together with the participants (e.g. forgotten foods, added phantom foods, inaccurately reported food frequencies, incorrect quantification of consumed portions and overestimation of seasonal foods). Portion size was estimated by models or photographs (Matmallen, Livsmeldelsverket, Uppsala). Daily intakes of food and nutrients were computed using food database and software systems developed at Section for Dietary Research, University of Oslo. The nutrient calculation did not include the use of cod liver oil or any other vitamin and mineral supplements.
Laboratory methods
Blood samples were collected by venepuncture at an initial screening (nonfasting), second screening (following an overnight fast), which were both conducted in 1972-1973, and at re-examination in 1997-1999 (following an overnight fast). Samples obtained at the second screening determined study eligibility and were collected at the same time as questionnaire and other clinical data. The fasting values obtained at the second screening were used in the current study. At this screening the concentrations of total cholesterol and triglycerides were estimated simultaneously by a Technicon Auto Analyser according to Technicon work sheets AAII-23 and AAII-24 (May 1971). The total cholesterol and triglyceride values obtained by this method are about 0.5 mmol/l higher than when obtained by enzymatic methods and were corrected using standard conversion factors (Leren et al., 1975) .
At the re-examination, serum lipid concentrations were determined by conventional enzymatic methods using automated analyser equipment (Hitachi 911; Hitachi Limited, Tokyo, Japan) and reagents from Boehringer Mannheim, Germany. These analyses were performed at the Department of Clinical Chemistry, Ullevål University Hospital, Oslo, Norway. Serum prepared for the analysis of fatty acids was kept frozen at À701C until analysis. In a random subset of participants (n ¼ 278), fatty acid composition was analysed by gas liquid chromatography using a Shimadzu GC 17-A gas chromatograph equipped with an auto injector AOC 14 and a flame ionisation detector (Shimadzu Corporation, Kyoto, Japan). A wall-coated opentubular fused silicia capillary column was used (Chrompack, Middelburg, The Netherlands). Pooled serum samples were used as reference. The interassay coefficients of variation for fatty acid peaks were 13% for linoleic acid, 24% for alinolenic acid, 20% for arachidonic acid, 18% for eicosapentanoic acid (EPA), and 29% for docosahexanoic acid (DHA).
Statistical methods
We compared changes in risk factors between baseline and the re-examination according to the subject's initial assignment to the intervention or control group. Baseline characteristics were compared by the Student's t-test. Categorical variables were compared using the w 2 test.
Within-group changes from baseline to the re-examination were compared with the paired t-test. Differences in changes between groups were compared with the independent samples t-test. Interaction the group assignment and each nutrient was examined using univariate analysis of variance with weight, BMI and height as dependent variables and each nutrient and group as the independent variables (none was found). Nutrient and dietary characteristics were compared by nonparametric tests (Kruskal-Wallis and Spearman's correlation coefficient). A two-sided P-value of p0.05 was considered as statistically significant. All calculations were carried out with SPSS (version 11, SPSS Inc., Chicago).
Results
Baseline and follow-up characteristics are summarised in Table 1 . About one-half of subjects in the control group and nearly one-half of subjects in the intervention group had quit smoking; however, smoking tended to be higher in the intervention versus the control group (Table 1 ; P ¼ 0.07).
Effect of diet and smoking on CHD I Ellingsen et al About 8% had developed diabetes. Over one-fourth of the subjects in the intervention and control groups had established cardiovascular disease, and of these 56% was taking statins. Use of statins was similar in both groups (Table 1) . Decreases in lipid concentrations were similar in the intervention and control groups, although the decrease in serum total cholesterol tended to be greater in intervention than control subjects who were treated with statins ( Table 2 ). The change in BMI from baseline to follow-up was correlated with the change in triglyceride concentration (Pearson's correlation coefficient ¼ 0.26; Po0.0001). Withingroup analyses showed that both groups had gained weight and increased in BMI whereas serum lipid concentrations decreased ( Table 2) . The fat quality score was significantly higher (more protective) in the intervention group at followup ( Table 2) . The intervention group reported greater attention to healthy living and a healthy diet, and a larger dietary change during and after participation in the study than the control group (Figure 1 ). Attention to a healthy diet was correlated with an improvement (increase) in the fat quality score (Pearson's correlation coefficient ¼ 0.14; P ¼ 0.001). The intervention group reported lower intakes of total fat, saturated fatty acids and cholesterol and a lower n-6/n-3 ratio than the control group (Table 3) . Daily intakes of protein, beta-carotene and long-chain polyunsaturated fatty acids (20:5 n-3 and 22:6 n-3) and the polyunsaturated/ saturated (PS)-ratio were higher in the intervention than the control group (Table 3) . Intake of micronutrients (calcium, iron, magnesium, vitamin C, thiamin, riboflavin, vitamin B 6 , vitamin E and folate) did not differ between the groups (data not shown). In regard to foods, the intervention group reported a higher intake of fish, vegetable cooking oil and skimmed milk and a lower intake of eggs, whole fat milk, low fat milk, total margarine and butter and hard margarine than the control group (Table 4) . Serum fatty acid concentrations were similar in both groups (Table 5 ). The intakes of total fish, fatty fish, polyunsaturated long chain fatty acids, cod liver oil, and Effect of diet and smoking on CHD I Ellingsen et al DHA, EPA and total omega-3 fatty acids as percent of energy were significantly correlated with DHA and EPA concentrations in serum (Pearson's correlation coefficients 0.17-0.44; Po0.01). The strongest correlations were between cod liver oil and DHA and EPA (Pearson's correlation coefficients ¼ 0.36-0.41) and between dietary total n-3 and EPA (Pearson's correlation coefficient ¼ 0.44).
Discussion
These findings suggest that dietary advice to reduce serum total cholesterol concentration may have sustained effects on the dietary intake of high-risk middle-aged men. Two decades following the end of the trial and cessation of dietary advice, intake of total and saturated fat and cholesterol was lower among men initially randomised to the dietary intervention group compared with controls. The difference in fat intake between the groups was compensated by a slightly higher intake of protein in the intervention group compared with the controls. The differences in fat and cholesterol intakes were primarily due to the substitution of skimmed milk for whole and low fat milk, vegetable oils for hard margarine and butter and a lower intake of eggs in the intervention group. Intake of fish and long-chain polyunsaturated fatty acids was higher in the intervention than in the control group. These dietary differences were not reflected in differences in serum lipid or fatty acid concentrations between the two groups. Moreover, the effects on the diet were modest; on a scale of 0 to 50, the difference in the fat quality score between the groups was o2 points, reflecting societal changes in the diet of the control group. Although body weight was reduced in the intervention group in the course of the trial , this difference was no longer apparent in survivors at the re-examination, and body weight and BMI increased in both groups.
These data extend the maintenance of changes in dietary fat and cholesterol intakes following dietary advice to two Effect of diet and smoking on CHD I Ellingsen et al and one-half decades from the initiation of the advice. At least two previous studies reported the persistence of dietary fat and cholesterol modification following the cessation of intervention in a clinical trial; one of these trials was conducted in women (Kristal et al., 1992) and the other in men (Cutler et al., 1991) . A follow-up of a feasibility trial of a low fat diet for the prevention of breast cancer showed that fat intake remained lower in the intervention and control groups 1 year after the trial ended (Kristal et al., 1992) . The Multiple Risk Factor Intervention Trial (MRFIT) aimed at dietary change and smoking cessation in high-risk men followed for 6-8 years (Gorder et al., 1986) . Cholesterollowering dietary changes were sustained 2-3.5 years after the end of the trial (Cutler et al., 1991) . These changes included increased intakes of poultry, skim milk, margarine and vegetable oils and decreased intakes of meats, whole milk, hard cheeses, butter, pastries, cream and ice cream in the intervention group, which were similar changes to those that were observed in the current study. In addition to these changes, men in the intervention group in the current study consumed more fish and less eggs than men in the control group. Notably, the decrease in fat intake in the intervention group was in part compensated with an increase in protein intake but not with an increase in added sugar. Thus, an increase in sugar intake does not seem to be an inevitable consequence of reducing fat intake, a phenomenon that has been called the sugar-fat seesaw (McColl, 1988) . Micronutrient and vitamin intakes were not compromised in the intervention group, which had a higher intake of betacarotene than the control group.
Our data have several limitations. Very long-term followup data are biased, because only survivors can be reexamined. Firstly, participants who died or became ill and did not attend the follow-up may have been more susceptible to the effects of cardiovascular risk factors than the survivors. Hence, the survivors are a healthy subset of the entire population. Moreover, men in the intervention group who were not compliant with the diet may have experienced premature mortality, leaving adherent subjects available for analysis. In addition, subject biases in reporting dietary intake and health attitudes due to the original group allocations cannot be ruled out. Despite these biases, the long-term effect of the intervention on dietary intake is of interest particularly in the light of previously published mortality data from the Oslo Diet and Antismoking Trial. These data showed that the protective effect of the intervention on coronary end points was maintained 8 years following randomisation, that is, 3 years after active advice ended (Hjermann et al., 1986) . Furthermore, in recent reports, we showed that in subgroups of the subjects with hypertriglyceridaemia or combined hyperlipidaemia, the intervention reduced CHD events for up to 23 years (Ellingsen et al., 2003; Hjerkinn et al., 2004) . Although the antismoking intervention contributed to the reduction in the events, statistical analysis showed that the reduction in cardiovascular death was primarily due to the decrease in serum cholesterol concentration Holme, 1982) and the change in smoking habits was only weakly correlated with the change in serum cholesterol concentration, with the one variable explaining only 2.5% of the variance in the other (data not shown); measurement of LDL and highdensity lipoprotein cholesterol was not performed and may have shown different results. Smoking is itself associated with an atherogenic diet and cessation with a reduction in saturated fatty acid and cholesterol intakes (Dallongeville et al., 1998) .
Another limitation is the self-reported nature of dietary data. Men in the intervention group may have biased their report of adherence in accordance with the dietary advice that they had been given. However, the participants were recruited to a new trial, and were not aware that their dietary practices would be compared according to the randomisation assignment in the previous trial. The difference in the dietary intake of the two groups was confirmed in the observation that men in the intervention group were more likely to report that they had changed their diet than men in the control group. The FFQ may have been less sensitive than dietary records or recalls to subtle changes in the diet that can affect fat intake. However, the FFQ used in the present study has been validated previously against 14-day weighed dietary records and against serum fatty acid concentrations and fatty acid patterns in adipose tissue (Andersen et al., 1999) . Moreover, long-chain polyunsaturated fat intake obtained from the FFQ correlated with serum DHA and EPA levels, providing validation of the FFQ in the current study subjects. The large interassay variation in the fatty acid measurements may have obscured any difference between the intervention and control groups.
The substantial decrease in serum total cholesterol concentrations from the start of the trial and the re-examination is in line with observed decreases in Norwegian men from the general population between 1974 and 1993 (Wøien et al., 1997) , as well as in other Western populations during these decades. In this data set, the changes are partly attributable to the observation that about one-fourth of the subjects had started treatment with statins. The improvement in dietary fat score in the control group suggests that some of the decrease in total serum cholesterol concentration may have been attributable to changes in the diet. Moreover, subjects that were not taking statins also had improved lipid concentrations.
Notably, serum triglyceride concentrations decreased in both the intervention and control groups despite an increase in BMI both in men treated or untreated with statins This observation suggests that an increase in BMI of about 1.5 kg/m 2 that accompanies aging does not necessarily lead to an increase in triglyceride concentrations. The change in BMI occurred in part because of a decrease in height (data not shown). Moreover, the increase in weight occurred in conjunction with smoking cessation and other favourable lifestyle and environmental changes (similar to those that Effect of diet and smoking on CHD I Ellingsen et al lowered lipid concentrations in the general population). Cigarette smoking increases insulin resistance, and cessation seems to increase insulin sensitivity despite increases in body weight (Eliasson et al., 1997) . Thus, smoking cessation seems to have only a minor effect on triglyceride concentrations (Green and Harari, 1995) . The prevalence of diabetes increased in both groups in accordance with the aging of the cohort, from none at baseline (men with diabetes were excluded) to about 8% at follow-up and was similar to the prevalence reported in Norwegian men aged 60-79 years that participated in a health survey in the late 1990s (Midthjell et al., 1999) .
Rates of cigarette smoking decreased in both groups, in accordance with changes in the general population (Statens Tobakkskaderåd, 1994) , and partly due to selective mortality of smokers. Although the intervention group had a higher rate of smoking cessation than the control group during the course of the intervention , this difference was no longer present in the survivors. This finding is similar to follow-up data on smoking reported by the MRFIT investigators. About 2-3.5 years after the end of the 6-8 year trial, there was no difference in cigarette smoking between the intervention and control groups, both because of relapse among men in the intervention arm of the trial and continuous smoking cessation in the population (Cutler et al., 1991) .
Conclusion
In summary, these findings suggest that dietary advice in the context of a CHD prevention trial had sustained, though modest, effects on the dietary intake of high-risk men for two decades after the cessation of the trial. Although the intervention did not influence long-term concentrations of lipids or fatty acids in survivors, previous data have documented the salutary effect of the dietary changes and smoking cessation on coronary events Hjermann, 1981; Hjermann et al., 1986; Ellingsen et al., 2003) .
